Patent 7252816 was granted and assigned to Dow Pharmaceutical Sciences on August, 2007 by the United States Patent and Trademark Office.
Increased compliance in the use of topical sunscreens is obtained by combining a topical sunscreen agent in a formulation containing an antibacterial medication such as azelaic acid or an antibiotic.